The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy

NCT04706429 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

154

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hypertrophic Cardiomyopathy

Interventions

DRUG: Trientine
DRUG: Placebo

Sponsor

Manchester University NHS Foundation Trust

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]